(Q45306426)

11 December 2017

title

Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures (English)

1 reference

11 December 2017

1 reference

Miguel A Hernán

1

1 reference

11 December 2017

Babette A Brumback

series ordinal

2

1 reference

11 December 2017

James M Robins

series ordinal

3

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

11 December 2017

published in

Statistics in Medicine

1 reference

11 December 2017

volume

21

1 reference

11 December 2017

issue

12

1 reference

11 December 2017

page(s)

1689-1709

1 reference

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

11 December 2017

cites work

1 reference

Correction for non-compliance in equivalence trials

21 January 2018

1 reference

The effects on survival of early treatment of human immunodeficiency virus infection

21 January 2018

1 reference

A controlled trial of zidovudine in primary human immunodeficiency virus infection

21 January 2018

1 reference

Longitudinal data analysis for discrete and continuous outcomes

21 January 2018

1 reference

On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9

21 January 2018

1 reference

Statistics and Causal Inference

21 January 2018

1 reference

A Generalization of Sampling Without Replacement from a Finite Universe

21 January 2018

1 reference

Likelihood analysis of multi-state models for disease incidence and mortality

21 January 2018

1 reference

Estimation of Regression Coefficients When Some Regressors are not Always Observed

21 January 2018

1 reference

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SIM.1144

1 reference

11 December 2017

1 reference